On September 12th in Stockholm, Ziccum CEO Ann Gidner delivered a compelling presentation at BioStock Investing in Life Science: From Seed to Success, garnering strong interest from life science leaders and investors.
The presentation showcased Ziccum’s innovative LaminarPace technology—a groundbreaking solution for the formulation and drying of delicate liquid biologics. The audience expressed significant interest in Ziccum’s advancements, recognizing the transformative impact LaminarPace could have on future biopharmaceuticals.
Please watch the full presentation here to discover more about LaminarPace and its significant role in addressing stability challenges, reducing production costs and increasing drying yield: https://youtu.be/T_OIl0LHrjw